Purpose: Cervical cancer significantly impacts global health, where early detection is piv- otal for improving patient outcomes. This study aims to enhance the accuracy of cervical cancer diagnosis by addressing class imbalance through a novel hybrid deep learning model.
Methods: The proposed model, RL-CancerNet, integrates EfficientNetV2 and Vision Transformers (ViTs) within a Reinforcement Learning (RL) framework. EfficientNetV2 extracts local features from cervical cytology images to capture fine-grained details, while ViTs analyze these features to recognize global dependencies across image patches. To address class imbalance, an RL agent dynamically adjusts the focus towards minority classes, thus reducing the common bias towards majority classes in medical image classification. Additionally, a Supporter Module incorporating Conv3D and BiLSTM layers with an attention mechanism enhances contextual learning.
Results: RL-CancerNet was evaluated on the benchmark cervical cytology datasets Herlev and SipaKMeD, achieving an exceptional accuracy of 99.7%. This performance surpasses several state-of-the-art models, demonstrating the model's effectiveness in identifying subtle diagnostic features in complex backgrounds.
Conclusions: The integration of CNNs, ViTs, and RL into RL-CancerNet significantly improves the diagnostic accuracy of cervical cancer screenings. This model not only advances the field of automated medical screening but also provides a scalable framework adaptable to other medical imaging tasks, potentially enhancing diagnostic processes across various medical domains.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11592902 | PMC |
http://dx.doi.org/10.3390/cancers16223782 | DOI Listing |
Sci Rep
January 2025
Gynecology Department, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China.
The presence of high-risk human papillomavirus (HR-HPV) contributes to the development of cervical lesions and cervical cancer. Recent studies suggest that an imbalance in the cervicovaginal microbiota might be a factor in the persistence of HR-HPV infections. In this study, we collected 156 cervicovaginal fluid (CVF) of women with HR-HPV infection, which were divided into three groups (negative for intraepithelial lesions = 78, low/high-grade squamous intraepithelial lesions = 52/26).
View Article and Find Full Text PDFSci Rep
January 2025
Research Institute for Applied Microelectronics (IUMA), University of Las Palmas de Gran Canaria (ULPGC), Las Palmas de Gran Canaria, Spain.
Cervical cancer remains a major global health concern, with a specially alarming incidence in younger women. Traditional detection techniques such as the Pap smear and colposcopy often lack sensitivity and specificity and are highly dependent on the experience of the gynaecologist. In response, this study proposes the use of Hyperspectral Imaging, a pioneering technology that combines traditional imaging with spectroscopy to provide detailed spatial and spectral information.
View Article and Find Full Text PDFSci Rep
January 2025
Prenatal Diagnosis Center in Guizhou Province, The Affiliated Hospital of Guizhou Medical University, Guizhou, Guiyang, 550009, China.
Cervical cancer (CESC) presents significant clinical challenges due to its complex tumor microenvironment (TME) and varied treatment responses. This study identified undifferentiated M0 macrophages as high-risk immune cells critically involved in CESC progression. Co-culture experiments further demonstrated that M0 macrophages significantly promoted HeLa cell proliferation, migration, and invasion, underscoring their pivotal role in modulating tumor cell behavior within the TME.
View Article and Find Full Text PDFRadiat Oncol
January 2025
Department of Respiratory Medicine and Medical Oncology, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Introduction: Stage IV non-small cell lung carcinoma (NSCLC) with oligometastases is potentially curable by radical treatment. This study aimed to evaluate the efficacy and safety of chemoradiotherapy (CRT) for thoracic disease, including the primary lesion and lymph node metastases, combined with local consolidative therapy (LCT) for oligometastases.
Methods: This was a multicenter Phase II trial for patients with Stage IV NSCLC with oligometastases for whom CRT for thoracic disease was feasible.
BMJ Case Rep
January 2025
Kansai Medical University, Hirakata Hospital, Hirakata, Japan.
SMARCA4-deficient undifferentiated cervical carcinoma is an extremely rare and aggressive malignancy, and effective treatment options are lacking. We experienced a rare case involving a patient with SMARCA4-deficient undifferentiated cervical carcinoma who was successfully managed in the long term. A woman in her 40s presented with a chief complaint of abnormal vaginal bleeding.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!